Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: An immunohistochemical study

Koichi Tsuneyama, Kenichi Harada, Mitsue Yasoshima, Kyosuke Kaji, M. Eric Gershwin, Yasuni Nakanuma

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Co-stimulatory factors B7-1 (CD80) and B7-2 (CD86) and their ligands, including CD28, are important for the efficient presentation and persistence of an antigen-specific immune reaction. Hitherto, there has been a paucity of data on the roles of such co-stimulatory factors in immune-mediated biliary diseases. In this investigation, the hepatic immunohistochemical expression of B7-1 and B7-2 has been studied, with emphasis on intrahepatic biliary epithelia, using wedge biopsies from 22 patients with primary biliary cirrhosis (PBC), seven with primary sclerosing cholagitis (PSC), and, as controls, eight cases of extrahepatic biliary obstruction, eight of chronic vital hepatitis C, and three histologically normal livers. In 10/22 (45 per cent) patients with PBC and 3/7 (43 per cent) patients with PSC, B7-2, but not B7-1, was expressed on the epithelial cells of small intrahepatic bile ducts and bile ductules. This expression was manifest as diffuse but variable cytoplasmic staining. Such B7-2-positive bile ducts were not seen in controls. Positive staining was found only in the early, stage of PBC and PSC. In PBC and PSC, almost all lymphocytes in the portal tracts, including those around the damaged bile ducts, were positive for CD28, a ligand of B7- 2. These results suggest that B7-2 expression on biliary epithelial calls is involved in antigen presentation and perhaps in bile duct destruction in PSC and PBC.

Original languageEnglish (US)
Pages (from-to)126-130
Number of pages5
JournalJournal of Pathology
Volume186
Issue number2
DOIs
StatePublished - Oct 1998

Fingerprint

Intrahepatic Bile Ducts
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Bile Ducts
Antigen Presentation
Staining and Labeling
Ligands
Liver
Immunologic Factors
Chronic Hepatitis C
Bile
Epithelium
Epithelial Cells
Lymphocytes
Biopsy

Keywords

  • B7-2
  • Co-stimulatory factor
  • Intrahepatic small bile ducts
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis : An immunohistochemical study. / Tsuneyama, Koichi; Harada, Kenichi; Yasoshima, Mitsue; Kaji, Kyosuke; Gershwin, M. Eric; Nakanuma, Yasuni.

In: Journal of Pathology, Vol. 186, No. 2, 10.1998, p. 126-130.

Research output: Contribution to journalArticle

Tsuneyama, Koichi ; Harada, Kenichi ; Yasoshima, Mitsue ; Kaji, Kyosuke ; Gershwin, M. Eric ; Nakanuma, Yasuni. / Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis : An immunohistochemical study. In: Journal of Pathology. 1998 ; Vol. 186, No. 2. pp. 126-130.
@article{7ff28c6b1c6f4081b8cf809e11f4ac2b,
title = "Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: An immunohistochemical study",
abstract = "Co-stimulatory factors B7-1 (CD80) and B7-2 (CD86) and their ligands, including CD28, are important for the efficient presentation and persistence of an antigen-specific immune reaction. Hitherto, there has been a paucity of data on the roles of such co-stimulatory factors in immune-mediated biliary diseases. In this investigation, the hepatic immunohistochemical expression of B7-1 and B7-2 has been studied, with emphasis on intrahepatic biliary epithelia, using wedge biopsies from 22 patients with primary biliary cirrhosis (PBC), seven with primary sclerosing cholagitis (PSC), and, as controls, eight cases of extrahepatic biliary obstruction, eight of chronic vital hepatitis C, and three histologically normal livers. In 10/22 (45 per cent) patients with PBC and 3/7 (43 per cent) patients with PSC, B7-2, but not B7-1, was expressed on the epithelial cells of small intrahepatic bile ducts and bile ductules. This expression was manifest as diffuse but variable cytoplasmic staining. Such B7-2-positive bile ducts were not seen in controls. Positive staining was found only in the early, stage of PBC and PSC. In PBC and PSC, almost all lymphocytes in the portal tracts, including those around the damaged bile ducts, were positive for CD28, a ligand of B7- 2. These results suggest that B7-2 expression on biliary epithelial calls is involved in antigen presentation and perhaps in bile duct destruction in PSC and PBC.",
keywords = "B7-2, Co-stimulatory factor, Intrahepatic small bile ducts, Primary biliary cirrhosis, Primary sclerosing cholangitis",
author = "Koichi Tsuneyama and Kenichi Harada and Mitsue Yasoshima and Kyosuke Kaji and Gershwin, {M. Eric} and Yasuni Nakanuma",
year = "1998",
month = "10",
doi = "10.1002/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1",
language = "English (US)",
volume = "186",
pages = "126--130",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis

T2 - An immunohistochemical study

AU - Tsuneyama, Koichi

AU - Harada, Kenichi

AU - Yasoshima, Mitsue

AU - Kaji, Kyosuke

AU - Gershwin, M. Eric

AU - Nakanuma, Yasuni

PY - 1998/10

Y1 - 1998/10

N2 - Co-stimulatory factors B7-1 (CD80) and B7-2 (CD86) and their ligands, including CD28, are important for the efficient presentation and persistence of an antigen-specific immune reaction. Hitherto, there has been a paucity of data on the roles of such co-stimulatory factors in immune-mediated biliary diseases. In this investigation, the hepatic immunohistochemical expression of B7-1 and B7-2 has been studied, with emphasis on intrahepatic biliary epithelia, using wedge biopsies from 22 patients with primary biliary cirrhosis (PBC), seven with primary sclerosing cholagitis (PSC), and, as controls, eight cases of extrahepatic biliary obstruction, eight of chronic vital hepatitis C, and three histologically normal livers. In 10/22 (45 per cent) patients with PBC and 3/7 (43 per cent) patients with PSC, B7-2, but not B7-1, was expressed on the epithelial cells of small intrahepatic bile ducts and bile ductules. This expression was manifest as diffuse but variable cytoplasmic staining. Such B7-2-positive bile ducts were not seen in controls. Positive staining was found only in the early, stage of PBC and PSC. In PBC and PSC, almost all lymphocytes in the portal tracts, including those around the damaged bile ducts, were positive for CD28, a ligand of B7- 2. These results suggest that B7-2 expression on biliary epithelial calls is involved in antigen presentation and perhaps in bile duct destruction in PSC and PBC.

AB - Co-stimulatory factors B7-1 (CD80) and B7-2 (CD86) and their ligands, including CD28, are important for the efficient presentation and persistence of an antigen-specific immune reaction. Hitherto, there has been a paucity of data on the roles of such co-stimulatory factors in immune-mediated biliary diseases. In this investigation, the hepatic immunohistochemical expression of B7-1 and B7-2 has been studied, with emphasis on intrahepatic biliary epithelia, using wedge biopsies from 22 patients with primary biliary cirrhosis (PBC), seven with primary sclerosing cholagitis (PSC), and, as controls, eight cases of extrahepatic biliary obstruction, eight of chronic vital hepatitis C, and three histologically normal livers. In 10/22 (45 per cent) patients with PBC and 3/7 (43 per cent) patients with PSC, B7-2, but not B7-1, was expressed on the epithelial cells of small intrahepatic bile ducts and bile ductules. This expression was manifest as diffuse but variable cytoplasmic staining. Such B7-2-positive bile ducts were not seen in controls. Positive staining was found only in the early, stage of PBC and PSC. In PBC and PSC, almost all lymphocytes in the portal tracts, including those around the damaged bile ducts, were positive for CD28, a ligand of B7- 2. These results suggest that B7-2 expression on biliary epithelial calls is involved in antigen presentation and perhaps in bile duct destruction in PSC and PBC.

KW - B7-2

KW - Co-stimulatory factor

KW - Intrahepatic small bile ducts

KW - Primary biliary cirrhosis

KW - Primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=0031697120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031697120&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1

DO - 10.1002/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1

M3 - Article

C2 - 9924426

AN - SCOPUS:0031697120

VL - 186

SP - 126

EP - 130

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -